A novel action of insulin on cardiac membrane.
Hiraoka
Masayasu
M
D000818:Animals; D002412:Cations; D002586:Cesium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004963:Estrenes / Q000494:pharmacology; D005682:Gadolinium / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology*; D007473:Ion Channels / Q000502:physiology*; D008094:Lithium / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D011188:Potassium / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011760:Pyrrolidinones / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors
D002412:Cations; D004963:Estrenes; D007093:Imidazoles; D007328:Insulin; D007473:Ion Channels; D011760:Pyrrolidinones; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D002586:Cesium; D008094:Lithium; D012964:Sodium; D005682:Gadolinium; C410467:insulin receptor tyrosine kinase; D011505:Protein-Tyrosine Kinases; D010738:Type C Phospholipases; C063159:1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole; D011188:Potassium